Development of plant-derived biomimetic nanoparticles as a novel targeted drug delivery platform

Abstract

Plant-derived biomimetic nanoparticles (PD-BNPs) have emerged as a very promising and sustainable alternative to traditional nanocarriers for targeted drug delivery. Synthetic nanoparticles provide great tunability but suffer from issues such as cytotoxicity, fast immunological elimination, and sustainability problems, while those of animal origin are restricted by limitations such as difficulties associated with scale-up and safety. On the other hand, plant-based biomimetic nanoparticles (PD-BNPs), especially plant-derived exosome-like nanoparticles, show great biocompatibility, low immunogenicity, and inherent therapeutic properties due to their phytochemicals, lipids, proteins, and RNA. They can provide antioxidant, anti-inflammatory, and immunomodulating activity. With developments in ultracentrifugation techniques, size exclusion chromatography, nanoemulsion technology and green synthesis methods, it has become possible to enhance the purification, stability, and scaling up of PD-BNPs. Natural tissue targeting capabilities and responsive properties make these nanoparticles ideal candidates for drug delivery. Despite some of the limitations, such as variations in sources and non-standardized production, these nanoparticles have immense applications in precision drug delivery and nanomedicine.

Keywords

controlled drug release / green synthesis / nanomedicine / plant extracellular vesicles / precision medicine / targeted drug delivery

References

[1] Zhang W, Wang J, Ngo L, Li L, Wang Y. recent advances in cancer cell membrane-based nanoparticles and cancer cell-derived small extracellular vesicles as drug delivery platforms. Adv NanoBiomed Res. 2025; 5(6), 2500008.

[2] Zhang F, Liang X, Liu H, Anayyat U, Yang Z, Wang X. Advancements and challenges of plant-derived extracellular vesicles in anti-cancer strategies and drug delivery. Curr Drug Deliv. 2025; 22(7): 921-934.

[3] Barzin M, Bagheri AM, Ohadi M, Abhaji AM, Salarpour S, Dehghannoudeh G. Application of plant-derived exosome-like nanoparticles in drug delivery. Pharm Dev Technol. 2023; 28(5): 383-402.

[4] Claridge B, Lozano J, Poh QH, Greening DW. Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities. Front Cell Dev Biol. 2021; 9: 734720.

[5] Xing H, Li G, Qi C, Zhang M, Ding N, Zhang X. Emerging role of plant-derived nanostructures in nanomedicine. Int J Nanomedicine. 2025; 20: 12715-12731.

[6] Calzoni E, Bertoldi A, Cusumano G, Buratta S, Urbanelli L, Emiliani C. Plant-derived extracellular vesicles: natural nanocarriers for biotechnological drugs. Processes. 2024; 12(12), 2938.

[7] Chen X, Ji S, Yan Y et al. Engineered Plant-derived nanovesicles facilitate tumor therapy: natural bioactivity plus drug controlled release platform. Int J Nanomedicine. 2023; 18: 4779-4804.

[8] Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021; 16(7): 748-759.

[9] Rao Q, Hua H, Zhao J. Advancements in Plant-derived sRNAs therapeutics: classification, delivery strategies, and therapeutic applications. Int J Mol Sci. 2025; 26(9), 4277.

[10] Rajasekaran B, Lo K, Pan M. Recent Advances in PDEVs as nanocarriers for drug delivery: loading techniques, engineering strategies and future directions. Expert Opin Drug Deliv 2025; 1-24.

[11] Isik S, Alhelwani S, Sahsahi A, Balcilar H, Yeman-Kiyak B. Plant-derived exosome-like nanovesicles: mechanisms and molecular understanding in neurological disorders with potential therapeutic applications. Drug Deliv Transl Res. 2025; 15(12): 4452-4478.

[12] Xu G, Jin J, Fu Z et al. Extracellular Vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther. 2025; 10: 255.

[13] Chen T, Chen D, Su W, Liang J, Liu X, Cai M. Extracellular Vesicles as vital players in drug delivery: a focus on clinical disease treatment. Front Bioeng Biotechnol. 2025; 13: 1600227.

[14] Li Z, Jin W, Zhu M et al. Plant-Derived Extracellular vesicles: emerging carriers for ingestible nucleotide delivery. Expert Opin Drug Deliv: 2025; 1-18.

[15] Li Y, Wang Y, Zhao H, Pan Q, Chen G. Engineering strategies of plant-derived exosome-like nanovesicles: current knowledge and future perspectives. Int J Nanomedicine. 2024; 19: 12793-12815.

[16] Zhang Q, Duan H, Yang Y, Yu H, Wang W, Li B. Recent advances in plant-derived extracellular vesicles as nanoparticles for cancer drug delivery. Int J Nanomedicine. 2025; 20: 14977-15016.

[17] Fu W, Zhang P, Wang W, Du M, Ni R, Sun Y. Frontiers of plant-derived exosomes from research methods to pharmaceutical applications in plant-based therapeutics. Curr Drug Deliv. 2025; 22(5): 522-536.

[18] Xiao Q, Zhao W, Wu C et al. Lemon-derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by endocytosis-triggered energy dissipation and energy production reduction. Adv Sci. 2022; 9(20), 2105274.

[19] Cui L, Perini G, Minopoli A, Palmieri V, De Spirito M, Papi M. Plant-derived extracellular vesicles as a natural drug delivery platform for glioblastoma therapy: a dual role in preserving endothelial integrity while modulating the tumor microenvironment. Int J Pharm X. 2025; 10: 100349.

[20] Chai M, Gao B, Wang S et al. Leveraging Plant-derived nanovesicles for advanced nucleic acid-based gene therapy. Theranostics. 2025; 15(1): 324-339.

[21] Zhao B, Lin H, Jiang X et al. Exosome-like nanoparticles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery. Theranostics. 2024; 14(12): 4598-4621.

[22] Leung KS, Shirazi S, Cooper LF, Ravindran S. Biomaterials and extracellular vesicle delivery: current status, applications and challenges. Cells. 2022; 11(18), 2851.

[23] Yang J, Wang Y, Fu Y et al. Plant extracellular vesicles: a promising bionic medicine platform for disease treatment and drug delivery. Interdiscip Med. 2025; 3(3), e20240101.

[24] Steć A, Targońska M, Jaikishan S et al. Incorporation of Doxorubicin into plant-derived nanovesicles: process monitoring and activity assessment. Drug Deliv. 2025; 32(1), 2439272.

[25] Pomatto MAC, Gai C, Negro F et al. Plant-derived extracellular vesicles as a delivery platform for RNA-based vaccine: feasibility study of an oral and intranasal SARS-CoV-2 vaccine. Pharmaceutics. 2023; 15(3), 974.

[26] Orefice NS, Di Raimo R, Mizzoni D, Logozzi M, Fais S. Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review. Expert Opin Ther Pat. 2023; 33(2): 89-100.

[27] Liu X, Lou K, Zhang Y, Li C, Wei S, Feng S. Unlocking the medicinal potential of plant-derived extracellular vesicles: current progress and future perspectives. Int J Nanomedicine. 2024; 19: 4877-4892.

[28] Jiang H, Kumarasamy RV, Pei J et al. Integrating engineered nanomaterials with extracellular vesicles: advancing targeted drug delivery and biomedical applications. Front Nanotechnol. 2025; 6: 1513683.

[29] Wu H, Shi M, Meng L et al. Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment. Front Cell Dev Biol. 2025; 13: 1589550.

[30] Kang SJ, Lee JH, Rhee WJ. Engineered plant-derived extracellular vesicles for targeted regulation and treatment of colitis-associated inflammation. Theranostics. Sep. 2024; 14(14): 5643-5661.

[31] Li J, Luo T, Wang D et al. Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease. J Adv Res. 2025; 68: 63-74.

[32] Li J, Wang Z, Wang F, Du X, Pang X. Plant-derived vesicles: isolation strategies and therapeutic applications. Front Plant Sci. 2026; 16: 1660579.

[33] Bai C, liu J, Zhang X et al. Research status and challenges of plant-derived exosome-like nanoparticles. Biomed Pharmacother. 2024; 174: 116543.

[34] Huang D, Chen J, Zhao M et al. Plant-derived extracellular vesicles: composition, function and clinical potential. J Transl Med. 2025; 23: 1065.

[35] Sha A, Luo Y, Xiao W et al. Plant-derived exosome-like nanoparticles: a comprehensive overview of their composition, biogenesis, isolation, and biological applications. Int J Mol Sci. 2024; 25(22), 12092.

[36] Yue Z, Yin J, Li Y. From nature to nanomedicine: engineered plant-derived nanovesicles for skin disease. Int J Nanomedicine. 2026; 21.

[37] Zeng H, Wang Q, Wang F et al. Extracellular vesicles derived from Citrus plants: innovative applications in therapeutics and drug delivery. J Nanobiotechnol. 2026; 24: 300.

[38] Trivedi R, Upadhyay TK, Mujahid MH et al. Recent advancements in plant-derived nanomaterials research for biomedical applications. Processes. 2022; 10(2), 338.

[39] Xu JY, Xiao YL, Yu ZL. From biomedical mechanisms to clinical applications: research progress in plant-derived vesicles for cancer therapy. Int J Nanomedicine. 2026; 21.

[40] Ding L, Chang C, Liang M, Dong K, Li F. Plant-derived extracellular vesicles as potential emerging tools for cancer therapeutics. Adv Therapeutics. 2024; 7: 2400256.

[41] Manzaneque MC, Cabán E, Ramirez P et al. Plant-derived nanovesicles and their clinical applications. in Curt Topics Membranes. 2025; 96: 229-275.

[42] Karamanidou T, Tsouknidas A. Plant-derived extracellular vesicles as therapeutic nanocarriers. Int J Mol Sci. 2022; 23(1), 191.

[43] Alsaid F, Davila B, He B. Plant-derived extracellular vesicles and nanoparticles: origins, functions, and applications. Front Bioeng Biotechnol. 2026; 14: 1758558.

[44] Xu Z, Xu Y, Zhang K et al.,. Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. J Nanobiotechnol. 2023; 21(1), 114.

[45] Mu N, Li J, Zeng L et al. Plant-derived exosome-like nanovesicles: current progress and prospects. Int J Nanomedicine. 2023; 18: 4987-5009.

[46] Chen Z, Xiong M, Tian J, Song D, Duan S, Zhang L. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. J Nanobiotechnology. 2024; 22: 18.

[47] Chen X, Xing X, Lin S et al. Plant-derived nanovesicles: harnessing nature's power for tissue protection and repair. J Nanobiotechnol. 2023; 21: 445.

[48] Jahromi LP, Fuhrmann G. A chemical toolbox for surface engineering of extracellular vesicles. Nat Rev Bioeng. 2025; 3(8): 332.

[49] Vanlalveni C, Lallianrawna S, Biswas A, Selvaraj M, Changmai B, Rokhum SL. Green synthesis of silver nanoparticles using plant extracts and their antimicrobial activities: a review of recent literature. RSC Adv. 2021; 11: 2804-2837.

[50] Pinedo M, de la Canal L, de Marcos Lousa C. A call for rigor and standardization in plant extracellular vesicle research. J Extracell Vesicles. 2021; 10: e12048.

[51] Huang Y, Wang S, Cai Q, Jin H. Effective methods for isolation and purification of extracellular vesicles from plants. J Integr Plant Biol. 2021; 63(12): 2020-2030.

[52] Wu C, Li J, Huang K et al. Advances in preparation and engineering of plant-derived extracellular vesicles for nutrition intervention. Food Chem. 2024; 457: 140199.

[53] Che K, Wang C, Chen H. Advancing functional foods: a systematic analysis of plant-derived exosome-like nanoparticles and their health-promoting properties. Front Nutr. 2025; 12: 1544746.

[54] Zou Z, Li H, Xu G, Hu Y, Zhang W, Tian K. Current knowledge and future perspectives of exosomes as nanocarriers in diagnosis and treatment of diseases. Int J Nanomedicine. 2023; 18: 4751-4778.

[55] Fu H, Yong S, Song Y et al. Advances in plant-derived extracellular vesicles: implications for apple-derived EVs. Plants. 2025; 14: 3425.

[56] Lian MQ, Chng WH, Liang J et al. Plant-derived extracellular vesicles: recent advancements and current challenges on their use for biomedical applications. J Extracell Vesicles. 2022; 11(12), e12283.

[57] Jianda X, Zimo Y, Yuhan D, Zhongyu X, Kewei Z, Xiaolan C. Plant-derived extracellular vesicles in diabetic wound healing: mechanisms, therapeutic implications and future perspectives. J Mater Sci Mater Med. 2025; 36: 107.

[58] Deng H, Zhang YW, Zhao QF, Huang ZJ. Medicinal plant-derived exosome-like nanoparticles: from basic research to biomedical applications. Pharmaceutics. 2026; 18(6), p. 750.

[59] Tangwattanachuleeporn M, Muanwien P, Teethaisong Y, Somparn P. Optimizing concentration of polyethylene glycol for exosome isolation from plasma for downstream application. Medicina. 2022; 58(11), 1600.

[60] Abada E, Mashraqi A, Modafer Y, Al Abboud MA, El-Shabasy A. Green synthesis of silver nanoparticles by using plant extracts and their antimicrobial activity: a review. Saudi J Biol Sci. 2024; 31(1), 103877.

[61] Huang L, Luo S, Tong S, Lv Z, Wu J. The development of nanocarriers for natural products. WIREs Nanomed Nanobiotechnol. 2024; 16(3), p. e1967.

[62] Petrovic S, Bita B, Barbinta-Patrascu M. Nanoformulations in pharmaceutical and biomedical applications: green perspectives. Int J Mol Sci. 2024; 25(11), p. 5842.

[63] Lo K, Wang M, Ho C, Pan M. Plant-derived extracellular vesicles: a new revolutionization of modern healthy diets and biomedical applications. J Agric Food Chem. 2024; 72(6): 2853-2878.

[64] Wang Y, Wu Y, Shen S et al. Engineered plant extracellular vesicles for natural delivery across physiological barriers. Food Funct. 2024; 15(4): 1737-1757.

[65] Hao S, Yang H, Hu J, Luo L, Yuan Y, Liu L. Bioactive compounds and biological functions of medicinal plant-derived extracellular vesicles. Pharmacol Res. 2024; 200: 107062.

[66] Kunjiappan S, Pavadai P, Vellaichamy S et al. Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: a state-of-the-art review. Drug Dev Res. 2021; 82(3): 309-340.

[67] Cong X, Chen J, Xu R. Recent Progress in bio-responsive drug delivery systems for tumor therapy. Front Bioeng Biotechnol. 2022; 10: 916952.

[68] Tan Z, Li J, Luo H, Liu Y, Jin Y. Plant extracellular vesicles: a novel bioactive nanoparticle for tumor therapy. Front Pharmacol. 2022; 13: 1006299.

[69] Huang H, Yi X, Wei Q et al. Edible and cation-free kiwi fruit-derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug-resistant lung cancer. J Nanobiotechnology. 2023; 21: 41.

[70] Rabienezhad Ganji N, Urzì O, Tinnirello V et al. Proof-of-concept study on the use of tangerine-derived nanovesicles as siRNA delivery vehicles toward colorectal cancer cell line SW480. Int J Mol Sci. 2024; 25(1), 546.

[71] Han R, Zhou D, Ji N et al. Folic acid-modified ginger-derived extracellular vesicles for targeted treatment of rheumatoid arthritis by remodeling immune microenvironment via the PI3K-AKT pathway. J Nanobiotechnology. 2025; 23: 41.

[72] Mammadova R, Pratiwi F, Fiume I et al. Tolvaptan-loaded tomato-derived nanovesicles: characterization and evaluation of cytotoxicity, wound healing potential and the effects on cyst formation in renal cell lines. Int J Nanomedicine. 2025; 20: 6253-6269.

[73] Nemidkanam V, Banlunara W, Chaichanawongsaroj N. Kaempferia parviflora extracellular vesicle loaded with clarithromycin for the treatment of helicobacter pylori infection. Int J Nanomedicine. 2024; 19: 1967-1983.

[74] Feng W, Teng Y, Zhong Q et al. Biomimetic grapefruit-derived extracellular vesicles for safe and targeted delivery of sodium thiosulfate against vascular calcification. ACS Nano. 2023; 17(24): 24773-24789.

[75] Fan S, Chen J, Tang C, Zhao Q, Zhang J, Qin Y. Edible plant extracellular vesicles: an emerging tool for bioactives delivery. Front Immunol. 2022; 13: 1028418.

[76] Wei C, Zhang M, Cheng J, Tian J, Yang G, Jin Y. Plant-derived exosome-like nanoparticles—from laboratory to factory, a landscape of application, challenges and prospects. Crit Rev Food Sci Nutr. 2025; 65(23): 1-19.

[77] Alzahrani FA, Khan MI, Kameli N, Alsahafi E, Riza YM. Plant-derived extracellular vesicles and their exciting potential as the future of next-generation drug delivery. Biomolecules. 2023; 13(5), 839.

[78] Eker F, Akdaşçi E, Duman H, Bechelany M, Karav S. Green synthesis of silver nanoparticles using plant extracts: a comprehensive review of physicochemical properties and multifunctional applications. Int J Mol Sci. 2025; 26(13), 6222.

[79] Fu H, Yong S, Song Y et al. Advances in plant-derived extracellular vesicles: implications for apple-derived EVs. Plants. 2025; 14(22), 3425.

[80] Ren H, Chen N, Liu Y et al. Preparation of oat galactolipid and anti-liver cancer effects of oat galactolipid-modified curcumin-loaded liver targeting vesicle. Front Pharmacol. 2025; 15: 1511666.

[81] Qiang W, Li J, Ruan R et al. Plant-derived extracellular vesicles as a promising anti-tumor approach: a comprehensive assessment of effectiveness, safety, and mechanisms. Phytomedicine. 2024; 130: 155750.

[82] Saffar A, Bahrami AR, Saljooghi AS, Matin MM. ZIF-8/doxorubicin nanoparticles camouflaged with cucurbita-derived exosomes for targeted prostate cancer therapy. J Mater Chem B. 2025; 13(19): 5705-5722.

[83] Chen Q, Zu M, Gong H et al. Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation. J Nanobiotechnol. 2023; 21: 6.

[84] Lv Qi, Yang H, Xie Y et al. Prunus mume-derived extracellular vesicle-like particles alleviate experimental colitis via disrupting NEK7-NLRP3 interaction and inflammasome activation. J Nanobiotechnology. 2025; 23: 532.

[85] Cui C, Du M, Zhao Y et al. Functional ginger-derived extracellular vesicles-coated ZIF-8 containing TNF-alpha siRNA for ulcerative colitis therapy by modulating gut microbiota. ACS Appl Mater Interfaces. 2024; 16: 53460-53473.

[86] Luo T, Hou L, Cao Y et al. Tea extracellular vesicle-derived micrornas contribute to alleviate intestinal inflammation by reprogramming macrophages. J Agric Food Chem. 2025; 73(11): 6745-6757.

[87] Khristiani Rahayu A, Fibriani A, Irasonia Tan M. Exploring the potential of black cumin-derived nanovesicles for mirna drug delivery. Eur J Pharm Biopharm. 2024; 199: 114275.

[88] Kim J, Zhu Y, Chen S et al. Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation. J Nanobiotechnol. 2023; 21: 253.

[89] Zhu Y, Zhao J, Ding H et al. Applications of plant-derived extracellular vesicles in medicine. MedComm. 2024; 5: e741.

[90] Wu H, Shi M, Meng L et al. Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment. Front Cell Dev Biol. 2025; 13: 1589550.

[91] Li De-F, Tang Qi, Yang M-F et al. Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease. Nanoscale Adv. 2023; 5: 3575-3588.

[92] Wei X, Li X, Zhang Y, Wang J, Shen S. Advances in the therapeutic applications of plant-derived exosomes in the treatment of inflammatory diseases. Biomedicines. 2023; 11(6), 1554.

[93] Cao T, Wan R, Li X et al. Tea-derived extracellular vesicles-mediated pdrn delivery activates cAMP-HIF-1alpha to restore intestinal homeostasis in inflammatory bowel disease. Mater Today Bio. 2025; 35: 102408.

[94] Liu C, Yan X, Zhang Y et al. Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J Nanobiotechnol. 2022; 20: 206.

[95] Li D, Yao X, Yue J et al. Advances in bioactivity of microRNAs of plant-derived exosome-like nanoparticles and milk-derived extracellular vesicles. J Agric Food Chem. 2022; 70: 6285-6299.

[96] Yang Lu-Y, Li C-Q, Zhang Yu-L, Ma M-W, Cheng W, Zhang G-J. Emerging drug delivery vectors: engineering of plant-derived nanovesicles and their applications in biomedicine. Int J Nanomedicine. 2024; 19: 2591-2610.

[97] Ding Le, Bian Q, Mou X, Chang X. Plant-derived exosome-like nanovesicles for CNS drug delivery and gut-brain axis modulation: a narrative review. Int J Nanomedicine. 2025; 20: 16093-16123.

[98] Jung D, Kim N-E, Kim S et al. Plant-derived nanovesicles and therapeutic application. Pharmacol Ther. 2025; 269: 108832.

[99] Yang Lu-Y, Liang G-Wu, Cai B-J et al. Enhanced tumor self-targeting of lemon-derived extracellular vesicles by embedding homotypic cancer cell membranes for efficient drug delivery. J Nanobiotechnology. 2025; 23: 74.

[100] Qiang W, Li J, Ruan R et al. Drug delivery of extracellular vesicles: preparation, delivery strategies and applications. Int J Pharm. 2023; 642: 123185.

[101] Jin Z, Na J, Lin X, Jiao R, Liu X, Huang Y. Plant-derived exosome-like nanovesicles: a novel nanotool for disease therapy. Heliyon. 2024; 10(9), e30630.

[102] Zhu Y, Zhou X, Yao Z. A mini-review: advances in plant-derived extracellular vesicles as nano-delivery systems for tumour therapy. Front Bioeng Biotechnol. 2022; 10: 1076348.

[103] Kürtösi B, Kazsoki A, Zelkó R. A systematic review on plant-derived extracellular vesicles as drug delivery systems. Int J Mol Sci. 2024; 25(14), 7559.

[104] Qiao Z, Zhang K, Liu J et al. Biomimetic electrodynamic nanoparticles comprising ginger-derived extracellular vesicles for synergistic anti-infective therapy. Nat Commun. 2022; 13: 7164.

[105] Lv L, Li Z, Liu X et al. Revolutionizing medicine: harnessing plant-derived vesicles for therapy and drug transport. Heliyon. 2024; 10(22), e40127.

[106] Kapoor DU, Sharma JB, Gandhi SM et al. AI-driven design and optimization of nanoparticle-based drug delivery systems. Sci Eng Health Stud. 2024; 18: 24010003.

[107] Yang J, Ai X, Zhang C, Guo T, Feng N. Application of plant-derived extracellular vesicles as novel carriers in drug delivery systems: a review. Expert Opin Drug Deliv. 2025; 22(6): 787-803.

[108] Yazdanpanah S, Romano S, Valentino A, Galderisi U, Peluso G, Calarco A. Plant-derived exosomes: carriers and cargo of natural bioactive compounds: emerging functions and applications in human health. Nanomaterials. 2025; 15(13), 1005.

[109] Shalvina A, Paul NA, Cummins SF, Eamens AL. Plant extracellular vesicles with complex molecular cargo: a cross-kingdom conduit for microRNA-directed RNA silencing. Genes. 2026; 17(1), 52.

[110] Zhou Yu, Zhao X, Li M et al. Plant-derived exosomes: an emerging delivery platform for cancer therapy. J Nanobiotechnol. 2026; 24: 195.

[111] Langellotto MD, Rassu G, Serri C, Demartis S, Giunchedi P, Gavini E. Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds. Drug Deliv Transl Res. 2025; 15: 831-845.

[112] Turner NP. Food-derived extracellular vesicles in the human gastrointestinal tract: opportunities for personalised nutrition and targeted therapeutics. J Extracell Biol. 2024; 3(5), e154.

[113] Fawzy MP, Hassan HAFM, Amin MU, Preis E, Bakowsky U, Fahmy SA. Deploying nucleic acids-loaded plant-derived exosomes as green nano gadget in cancer gene therapy. Mater Adv. 2025; 6(4): 1230-1261.

[114] Guo H et al. Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy. Biomater Transl. 2024; 5(1): 33-45.

[115] Wang H, Mu J, Chen Y et al. Hybrid ginseng-derived extracellular vesicles-like particles with autologous tumor cell membrane for personalized vaccination to inhibit tumor recurrence and metastasis. Adv Sci. 2024; 11: 2308235.

[116] Fang J and Liu H. Plant-derived extracellular vesicles as oral drug delivery carriers. J Control Release. 2022; 350: 389-400.

[117] Fuhrmann G. Drug delivery as a sustainable avenue to future therapies. J Control Release. 2023; 354: 746-754.

[118] Hu M, Han Y, Zhang X et al. Extracellular vesicles for targeted drug delivery: advances in surface modification strategies and therapeutic applications. J Transl Med. 2025; 23: 1028.

[119] Wang X, Xin C, Zhou Y, Sun T. Plant-derived vesicle-like nanoparticles: the next-generation drug delivery nanoplatforms. Pharmaceutics. 2024; 16(5), 588.

[120] Kim SQ and Kim K-H. Emergence of edible plant-derived nanovesicles as functional food components and nanocarriers for therapeutics delivery: potentials in human health and disease. Cells. 2022; 11(14), 2232.

[121] Jo HY, Kang SJ, Kim G, Gwak S, Baek G, Rhee WJ. Plant-derived extracellular vesicles: current status and challenges for developing a new paradigm in therapeutics development. VIEW. 2025; 6: 20240115.

[122] Chen F, Bao R, Yang W et al. Engineered plant extracellular vesicles: emerging nanoplatforms for combinational cancer immunotherapy. Acta Pharm Sin B. 2025; 15(11): 5663-5701.

[123] Kang SJ and Rhee WJ. Engineered plant-derived extracellular vesicles as targeted drug carriers in cancer therapy. ACS Appl Bio Mater. 2026; 9(2): 1053-1063.

[124] Liu H, Deng Yi, Li J et al. Ginger-derived exosome-like nanoparticles: a representative of plant-based natural nanostructured drug delivery system. Front Bioeng Biotechnol. 2025; 13: 1569889.

[125] Wang Y, Xiong J, Ouyang K et al. Extracellular vesicles: from large-scale production and isolation to clinical translation. J Tissue Eng. 2025; 16.

[126] Greenberg ZF, Graim KS, He M. Towards artificial intelligence-enabled extracellular vesicle precision drug delivery. Adv Drug Deliv Rev. 2023; 199: 114974.

[127] Eugster R, Orsi M, Buttitta G, et al. Leveraging machine learning to streamline the development of liposomal drug delivery systems. J Control Release. 2024; 376: 1025-1038.

[128] Youssef E, Palmer D, Fletcher B, Vaughn R. Exosomes in precision oncology and beyond: from bench to bedside in diagnostics and therapeutics. Cancers. 2025; 17(6), 940.

[129] Nueraihemaiti N, Dilimulati D, Baishan A et al. Advances in plant-derived extracellular vesicle extraction methods and pharmacological effects. Biology. 2025; 14(4), 377.

[130] Seegobin N, Abdalla Y, Li Ge, Murdan S, Shorthouse D, Basit AW. Optimising the production of PLGA nanoparticles by combining design of experiment and machine learning. Int J Pharm. 2024; 667: (pt. A), 124905.

[131] Hanari N, Mihandoost S, Rezvantalab S. Intelligence prediction of microfluidically prepared nanoparticles. Sci Rep. 2025; 15: 37512.

[132] Mi K, Chou W-C, Chen Q et al. Predicting tissue distribution and tumor delivery of nanoparticles in mice using machine learning models. J Control Release. 2024; 374: 219-229.

[133] Khokhlov I, Legashev L, Bolodurina I, Shukhman A, Shoshin D, Kolesnik S. Prediction of dynamic toxicity of nanoparticles using machine learning. Toxics. 2024; 12(10), 750.

[134] Bae H, Ji H, Konstantinov K et al. Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery. Adv Mater. 2025; 37(42), e10239.

[135] Shu F, Hu Y, Sarsaiya S et al. Plant-derived extracellular vesicles quality control: key process progress and future research directions. Discover Nano. 2025; 20: 233.

[136] Huanbutta K, Burapapadh K, Kraisit P et al. Artificial intelligence-driven pharmaceutical industry: a paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. Eur J Pharm Sci. 2024; 203: 106938.

[137] Tiwari A, Widodo , Krisnawati DI, Tzou K-Yi, Kuo T-R. Machine learning for extracellular vesicles enables diagnostic and therapeutic nanobiotechnology. J Nanobiotechnol. 2026; 24: 153.

[138] Han Y, Kim DH, Pack SP. Nanomaterials in drug delivery: leveraging artificial intelligence and big data for predictive design. Int J Mol Sci. 2025; 26(22), 11121.

[139] Wang Q, Liu Y, Li C, Xu B, Xu S, Liu B. Machine learning-enhanced nanoparticle design for precision cancer drug delivery. Adv Sci. 2025; 12(30), e03138.

[140] Ortiz-Perez A, Van Tilborg D, Van Der Meel R, Grisoni F, Albertazzi L. Machine learning-guided high-throughput nanoparticle design. Digital Discy. 2024; 3(7): 1280-1291.

[141] Mahdi WA, Alhowyan A, Obaidullah AJ. Intelligence analysis of drug nanoparticles delivery efficiency to cancer tumor sites using machine learning models. Sci Rep. 2025; 15: (1017).

[142] Sayed GI, Alshater H, Hassanien AE. Predicting the potential toxicity of metal oxide nanoparticles using machine learning algorithms. Soft Comput. 2024; 28: 10235-10261.

[143] Panchpuri M, Painuli R, Kumar C. Artificial intelligence in smart drug delivery systems: a step toward personalized medicine. RSC Pharm. 2025; 2(5): 882-914.

[144] Abdulhussain R, Muhamad H, Fiza T et al. The integration of artificial intelligence through quality by digital design for sustainable pharmaceutical manufacturing. Int J Pharm. 2026; 693: (126682).

[145] Chou W-C, Canchola A, Zhang F, Lin Z. Machine learning and artificial intelligence in nanomedicine. WIREs Nanomed Nanobiotechnol. 2025; 17(4), e70027.

[146] Lu H, Zhang J, Shen T, Jiang W, Liu H, Su J. Harnessing artificial intelligence for engineering extracellular vesicles. Extracell Vesicles Circ Nucleic Acids. 2025; 6: 517-541.

[147] Zeng Y-B, Deng X, Shen L-S et al. Advances in plant-derived extracellular vesicles: isolation, composition, and biological functions. Food Funct. 2024; 15(23): 11319-11341.

[148] Thieron H, Krassini L, Kwon S et al. Practical advice for extracellular vesicle isolation in plant-microbe interactions: concerns, considerations, and conclusions. J Extracell Vesicles. 2024; 13: e70022.

[149] Nieuwland R, Falcón-Pérez JM, Théry C, Witwer KW. Rigor and standardization of extracellular vesicle research: paving the road towards robustness. J Extracell Vesicles. 2020; 10: e12037.

[150] Zhang Z et al. Plant-derived nanovesicles: resolving conceptual confusion, overcoming isolation challenges, and advancing translational potential. Int J Nanomedicine. 2026; 21: 1-19.

[151] Koo S et al. Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles. Nanomedicine. 2020; 29: 102271.

[152] Welsh JA, Goberdhan DCI, O'Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024; 13: e12404.

[153] Shinge SAU, Xiao Y, Xia J, Liang Y, Duan Li. New insights of engineering plant exosome-like nanovesicles as a nanoplatform for therapeutics and drug delivery. Extracell Vesicles Circ Nucleic Acids. 2022; 3(2): 150-162.

[154] Ahmadian S, Jafari N, Tamadon A, Ghaffarzadeh A, Rahbarghazi R, Mahdipour M. Different storage and freezing protocols for extracellular vesicles: a systematic review. Stem Cell Res Ther. 2024; 15: 453.

[155] Takakura Y, Hanayama R, Akiyoshi K et al. Quality and safety considerations for therapeutic products based on extracellular vesicles. Pharm Res. 2024; 41: 1573-1594.

[156] Huang J et al. Emerging Technologies towards extracellular vesicles large-scale production. Bioact Mater. 2025; 52: 338-365.

[157] Thakur A and Rai D. Global requirements for manufacturing and validation of clinical grade extracellular vesicles. J Liquid Biopsy. 2024; 6: 100278.

[158] Zhang J, Pan Y, She P, Rao L. From bench to bedside: the promise and roadblocks of extracellular vesicle therapeutics. Theranostics. 2026; 16(9): 5044-5064.

Rights & permissions

2026 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.